Virtus Fund Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Virtus Fund Advisers’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$980K	Buy	+210,666	New	+$1.16M	0.01%	292
2017 Q1	–	Sell	-55,878	Closed	-$327K	–	562
2016 Q4	$327K	Hold	55,878	–	–	﹤0.01%	381
2016 Q3	$297K	Hold	55,878	–	–	﹤0.01%	385
2016 Q2	$380K	Hold	55,878	–	–	﹤0.01%	368
2016 Q1	$261K	Sell	55,878 -12,070	-18%	-$48.2K	﹤0.01%	389
2015 Q4	$343K	Sell	67,948 -714	-1%	-$3.39K	﹤0.01%	369
2015 Q3	$242K	Sell	68,662 -102,028	-60%	-$683K	﹤0.01%	366
2015 Q2	$1.7M	Buy	170,690 +40,734	+31%	+$437K	0.01%	323
2015 Q1	$1.65M	Sell	129,956 -12,091	-9%	-$155K	0.01%	333
2014 Q4	$2.01M	Buy	142,047 +687	+0.5%	+$10.6K	0.01%	331
2014 Q3	$1.94M	Sell	141,360 -6,811	-5%	-$104K	0.01%	340
2014 Q2	$2.28M	Buy	+148,171	New	+$2.1M	0.02%	354

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Virtus Fund Advisers's KERX Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Keryx Biopharmaceuticals Inc (KERX) in Q4 2017: 210,666 shares worth $980K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in KERX as recently as Q4 2016.

Virtus Fund Advisers first reported a position in KERX in Q2 2014 and has held it in 12 quarters since. The position peaked at $2.28M in Q2 2014. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

Virtus Fund Advisers held 210,666 shares of Keryx Biopharmaceuticals Inc worth $980K as of Q4 2017.
Keryx Biopharmaceuticals Inc was a new Virtus Fund Advisers position in Q4 2017.
Keryx Biopharmaceuticals Inc made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #292 holding.
Virtus Fund Advisers first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and has held it in 12 quarters since.
Virtus Fund Advisers's Keryx Biopharmaceuticals Inc position peaked at $2.28M in Q2 2014.
129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.